Comparison of positive tuberculin skin test with an interferon-gamma-based assay in unexposed children.

A false-positive tuberculin skin test (TST) may be a result of T-cell sensitivity due to Bacille Calmette-Guerin (BCG) vaccination or exposure to non-tuberculous mycobacteria, thus leading to unnecessary isoniazid preventive therapy, especially in low-risk populations. Unlike TST, T-SPOT.TB is not confounded by BCG vaccination or exposure to most of the other non-tuberculous mycobacteria, because this assay is based on enumeration of interferon-gamma-secreting T cells in response to Mycobacterium tuberculosis-specific antigens. We compared the TST with T-SPOT.TB with respect to different TST cut-off points in healthy unexposed BCG-vaccinated schoolchildren. A total of 209 children between 6 and 10 years of age with a TST induration of 0 (n = 50), 10 - 14 (n = 45), 15 - 19 (n = 95) and > or =20 mm (n = 19) were enrolled. Among TST-positive subjects, only 26 (23%) were positive with T-SPOT.TB, and T-SPOT.TB was positive in 4, 7, 20 and 42% of children with TST indurations of 0, 10 - 14, 15 - 19 and > or =20 mm, respectively. We suggest that confirmation of a positive TST by the interferon-gamma-based test would reduce unnecessary preventive therapy significantly in healthy unexposed BCG-vaccinated children.

[1]  T. Mori,et al.  Waning of the specific interferon-gamma response after years of tuberculosis infection. , 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[2]  T. Porco,et al.  Cost-effectiveness of Alternative Strategies for Tuberculosis Screening Before Kindergarten Entry , 2007, Pediatrics.

[3]  F. Spieth,et al.  Falsch-positiver Interferon-γ-Test? , 2007, Pneumologie.

[4]  Kunihiko Ito,et al.  [Liver damage in treatment of latent tuberculous infection by isoniazid]. , 2006, Kekkaku : [Tuberculosis].

[5]  M. Pai,et al.  False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[6]  J. Deeks,et al.  Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. , 2006, American journal of respiratory and critical care medicine.

[7]  P. Wrighton-Smith,et al.  Direct costs of three models for the screening of latent tuberculosis infection , 2006, European Respiratory Journal.

[8]  J. Deeks,et al.  Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study , 2005, The Lancet.

[9]  V. Chadha,et al.  Tuberculin sensitivity among children vaccinated with BCG under universal immunization programme , 2004, Indian journal of pediatrics.

[10]  J. Fitzgerald,et al.  A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements , 2002, Thorax.

[11]  I. O. Ipek,et al.  Effect of BCG vaccine on tuberculin skin tests in 1‐6‐year‐old children , 2002, Acta paediatrica.

[12]  C. Chee,et al.  Interpretation of the tuberculin skin test in Mycobacterium bovis BCG-vaccinated Singaporean schoolchildren. , 2001, American journal of respiratory and critical care medicine.

[13]  J. Deeks,et al.  Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells , 2001, The Lancet.

[14]  T. Arnadottir,et al.  Prevalence and annual risk of tuberculosis infection in Laos. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[15]  R. Wilkinson,et al.  Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. , 2001, American journal of respiratory and critical care medicine.

[16]  G. Schoolnik,et al.  Comparative genomics of BCG vaccines by whole-genome DNA microarray. , 1999, Science.

[17]  M. Borgdorff,et al.  Trend in the annual risk of tuberculous infection in Egypt, 1950-1996. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[18]  G. Mahairas,et al.  Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis , 1996, Journal of bacteriology.

[19]  Christopher J. L. Murray,et al.  Tuberculosis: Commentary on a Reemergent Killer , 1992, Science.

[20]  K. H. Hsu,et al.  Thirty years after isoniazid. Its impact on tuberculosis in children and adolescents. , 1984, JAMA.

[21]  G W Comstock,et al.  The prognosis of a positive tuberculin reaction in childhood and adolescence. , 1974, American journal of epidemiology.

[22]  D. T. Carr.  The tuberculin skin test. , 1972, The American review of respiratory disease.